Prometheus Laboratories Presents Research Showing Superior Performance of MASH Precis™ Fibrosis Score in Identifying Treatment-Eligible Patients
News & Events Prometheus Laboratories [...]
About Chrystal Johnson
This author has not yet filled in any details.So far Chrystal Johnson has created 13 blog entries.
Prometheus Laboratories Launches MASH Precis™, a Purpose-Built Non-Invasive Test Designed to Support Evolving MASH Pathways
News & Events Prometheus Laboratories [...]
Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing Collaboration on Anser® IFX for ZYMFENTRA® (infliximab-dyyb)
News & Events Celltrion USA [...]
Prometheus Signals Near Term Development of Next Generation Noninvasive Test for MASH Patients at DDW® 2026
News & Events Prometheus Signals [...]
Prometheus Laboratories Showcases Drug Clearance as a Foundation for Precision Guided Biologic Dosing in IBD at DDW® 2026
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Launches IBD Precis™ Featuring Breakthrough Colonic Markers to Transform UC and CD Assessment
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Announces Collaboration with Celltrion for Anser® Testing
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Expands Precision-Guided Dosing Tests with the Launch of PredictrPK® VDZ and UST
News & Events Prometheus Laboratories [...]
PredictrPK® ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study
News & Events PredictrPK® ADA, [...]
Prometheus Laboratories Presents Novel Data on Precision-Guided Care in IBD at DDW® 2025
News & Events Prometheus Laboratories [...]